PhRMA v. HHS
Executive Summary
Oral arguments in Pharmaceutical Research & Manufacturers of America's suit vs. HHS over Michigan's Medicaid supplemental rebate program scheduled for Aug. 28 in D.C. federal court (1"The Pink Sheet" July 8, p. 11)...
You may also be interested in...
PhRMA Takes Michigan Rebate Dispute To Federal Court Ahead Of Payments
The Pharmaceutical Research & Manufacturers of America is moving its challenge against Michigan Medicaid's supplemental rebate program to federal court in advance of the first round of rebate payments
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.